Published Sep 11, 2024

#143 Vital Audio

In this episode, Josh Muccio delves into Vital Audio, a pioneering healthtech startup that uses vocal biomarkers to assess vital signs with a live demo, personal anecdotes, and a deep dive into regulatory challenges and market opportunities for this innovative technology.
Episode Highlights
The Pitch logo

Popular Clips

Questions from this episode

Episode Highlights

  • FDA Exemption

    Vital Audio's journey to secure FDA exemption was a meticulous process. personally undertook the task, dedicating three months to complete the necessary homework and pre-submission. This effort resulted in a non-significant risk designation from the FDA, allowing them to deploy their technology for large-scale data acquisition 1.

    The FDA has actually shared that it's the first technology that they have encountered that takes in vocal frequencies or signals.

    ---

    With an accuracy rate of 92-94%, they aim to branch into diagnostics, leveraging the data collected this year 1.

       

    Regulatory Challenges

    Navigating regulatory challenges was a significant part of Vital Audio's journey. highlighted the uniqueness of their technology, which uses vocal frequencies, making it the first of its kind reviewed by the FDA 1. This novelty posed challenges but also opportunities for innovation.

    It's a sticker and you have to shower with it and you have to put plastic all over your chest.

    --- Charles Hudson

    Investors like Charles Hudson and recognized the potential of this technology to revolutionize cardiac monitoring and telehealth, emphasizing the need for compliance and ease of use in healthcare solutions 2.

Related Episodes